Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

NCT03833167

Conditions
Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +3 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 1562) Mobile, Alabama, United States
  • City of Hope Medical Center ( Site 1505) Duarte, California, United States
  • UCSD Moores Cancer Center ( Site 1561) La Jolla, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1568) Los Angeles, California, United States
View all 181 locations
View Trial Details
Completed

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

NCT00939627

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Suburban Hospital Bethesda, Maryland, United States
View Trial Details
Completed

Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

NCT03142334

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Arizona Oncology Associates, PC- HAL ( Site 8018) Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center ( Site 0038) Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0056) San Francisco, California, United States
  • Sansum Clinic Research ( Site 8014) Santa Barbara, California, United States
View all 251 locations
View Trial Details
Completed

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

NCT05665348

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations
  • Chu Amiens Picardie Amiens, France
  • CHU Angers, France
  • Privé LES BONNETTES Arras, France
  • Chu Avicienne Bobigny, France
View all 45 locations
View Trial Details
Completed

Bristol Bladder Trial

NCT01616875

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Bristol Haematology + Oncology Centre, Horfield Road Bristol, United Kingdom
View Trial Details

Related conditions